全球百日咳倡议:按经济体优先级控制百日咳的建议更新
全球百日咳倡议(GPI)基于临床试验、观察和监测数据,系统评估并优先排序了通过疫苗接种策略和公共卫生政策预防百日咳相关婴儿和儿童死亡、降低全球疾病负担并防止复发的策略。建议中低收入国家优先实现婴儿系列百日咳疫苗高覆盖率,若当前使用全细胞百日咳(wP)疫苗则应继续使用;在资源允许时所有国家应优先实施孕期无细胞百日咳(aP)免疫;并建议在资源允许时,幼儿、青少年、医护人员和托幼工作者接种加强剂次。
要点
- 中低收入国家应优先实现婴儿系列百日咳疫苗高覆盖率。
- 中低收入国家和疫苗资金受限国家若当前使用wP疫苗,应继续使用wP。
- 资源允许时所有国家应优先实施孕期aP免疫。
核心结论
- GPI建议中低收入国家优先实现婴儿系列百日咳疫苗高覆盖率,并在资源允许时优先实施孕期aP免疫及对特定人群接种加强剂次。
研究设计与样本
- GPI建议基于临床试验、观察和监测数据,源自2016年11月11-13日在南非开普敦举行的GPI会议讨论。
主要发现
- 许多中低收入国家继续使用wP疫苗进行基础免疫,而大多数高收入国家已用反应原性较低的aP疫苗替代wP。
- 百日咳是疫苗可预防疾病,尤其在婴儿和5岁以下儿童中导致发病和死亡。
关键数值与推荐
- GPI建议中低收入国家以婴儿系列百日咳疫苗高覆盖率为目标作为优先事项。
- 在中低收入国家和疫苗资金受限国家,若当前使用wP疫苗,应继续使用wP。
- GPI建议若资源允许,所有国家应优先实施孕期aP免疫。
- GPI建议在实施wP疫苗的地区,考虑众多不同制造商及生产和质量控制标准可变,应检查wP疫苗的标准化和校准。
- GPI进一步建议若资源允许,幼儿、青少年、医护人员和托幼工作者接种加强疫苗剂次。
临床怎么用
- 中低收入国家应优先追求婴儿系列百日咳疫苗高覆盖率。
- 疫苗资金受限国家若当前使用wP疫苗,应继续使用wP而非转换。
- 资源允许时,所有国家应优先实施孕期aP免疫以预防新生儿百日咳疾病和死亡。
- 资源允许时,应为幼儿、青少年、医护人员和托幼工作者接种加强剂次。
- 使用wP疫苗的地区应检查wP疫苗的标准化和校准。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pertussis is a vaccine-preventable disease that causes morbidity and mortality, particularly in infants and children <5 years of age. The Global Pertussis Initiative (GPI) recommendations represent a systematic evaluation and prioritization of strategies to prevent pertussis-related infant and child deaths, reduce global disease burden and prevent resurgence through vaccination strategies and public health policies at national, regional and local levels. The GPI recommendations are based on clinical trials and observational and surveillance data, which are essential in the planning, implementation and evaluation of vaccination practices and best use of available resources. Many low- and middle-income countries (LMIC) continue to use whole-cell pertussis (wP) vaccines for primary vaccination, while most high-income countries have replaced wP with the less-reactogenic acellular pertussis (aP) vaccines. This present manuscript pertains to discussions held during the GPI's meeting on November 11-13, 2016, in Cape Town, Republic of South Africa. The GPI recommends that LMIC aim for high coverage of infant series pertussis vaccines as a priority. In LMIC and countries with constrained vaccine funding, if wP vaccines are currently used, wP should continue to be used. Furthermore, given that protection against disease and death due to pertussis in neonates is a key priority of the GPI, it recommends that ap immunization in pregnancy should be implemented as a priority in all countries if resources allow. Given that surveillance and epidemiology data on which to base vaccine decisions are important, the GPI also suggests that, in areas where wP vaccines are implemented, standardization and calibration of wP vaccines are checked, considering the many different manufacturers and variable standards of production and quality control. In addition, as immunity to pertussis wanes following the primary infant series of vaccination, the GPI further recommends that toddlers, adolescents, healthcare and childcare workers receive booster vaccine doses, where resources allow.
引用
- Forsyth KD, Tan T, von König CW, et al. Recommendations to control pertussis prioritized relative to economies: A Global Pertussis Initiative update. Vaccine. 2018. PMID: 30337176. doi:10.1016/j.vaccine.2018.10.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。